Nexalin Technology files debt obligation with SEC
The company submitted an 8-K filing covering debt obligations and related items.
Nexalin Technology, Inc. filed an 8-K form with the SEC on August 21, 2026, covering items 1.01, 2.03, and 9.01.[1]
The filing was recorded under accession number 0001829126-26-009226 and included a debt obligation event.[1]
Nexalin Technology, Inc. is incorporated in Delaware and trades on Nasdaq under the ticker NXL.[2]
The company operates in the electromedical and electrotherapeutic apparatus sector.[2]
Nexalin Technology, Inc. received a delisting notice on August 17, 2026, prior to the filing.[3]